018637184

STIM-R (SYNTHETIC T CELL IMMUNE MICROENVIRONMENT-REPROGRAMMING)

---

January 11, 2022

Trademark Summary

The trademark application STIM-R (SYNTHETIC T CELL IMMUNE MICROENVIRONMENT-REPROGRAMMING) was filed by Lyell Immunopharma, Inc., a U.S. corporation (the "Applicant"). The application was published for oppositions on June 12, 2022, and still open for oppositions.

The application was filed in English (Italian was selected as the second language).

---

Goods And Services

• The mark was filed in class 1 with following description of goods:
  
  1. Chemical, biological and biochemical products for research and scientific purposes
  2. Reagents for programmable culturing of biological material
  3. Reagents for use in biotechnology.
• The mark was filed in class 5 with following description of goods:
  
  1. Pharmaceutical, medical and veterinary preparations
  2. Reagents for the processing and culturing of biological material for medical purposes
  3. Chemical, biological and biochemical preparations for medical purposes
  4. Chemical, biological and biochemical products for medical purposes
  5. Reagents for use in biological treatment.
• The mark was filed in class 42 with Medical, pharmaceutical and biotechnological research and Scientific and technological services, and biological research and development relating thereto..
• The mark was filed in class 44 with Medical services.